Literature DB >> 911600

Adverse reactions to procainamide.

D H Lawson, H Jick.   

Abstract

1 Data from a comprehensive drug surveillance programme are analysed to provide details of procainamide use and toxicity in medical wards of teaching hospitals in five countries. 2 Out of a total of 488 recipients 9.2% had one or more adverse effect attributed to the drug; common effects being arrhythmias, gastro-intestinal upsets and drug fever. Although occasionally of major severity, no patient died as a consequence of procainamide toxicity. 3 Toxicity was directly related to total daily dose and duration of hospitalization but was not related to age, weight of the patient or presenting urea or albumin concentrations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911600      PMCID: PMC1429167          DOI: 10.1111/j.1365-2125.1977.tb00777.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Prophylactic procaine amide in myocardial infarction.

Authors:  P C REYNELL
Journal:  Br Heart J       Date:  1961-07

2.  Use of plasma levels in evaluation of procainamide dosage.

Authors:  T R Shaw; C R Kumana; R B Royds; C M Padgham; J Hamer
Journal:  Br Heart J       Date:  1974-03

3.  Long-term use of procaine amide following acute myocardial infarction.

Authors:  B D Kosowsky; J Taylor; B Lown; R F Ritchie
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

4.  Procainamide-induced lupus erythematosus. Clinical and laboratory observations.

Authors:  S E Blomgren; J J Condemi; J H Vaughan
Journal:  Am J Med       Date:  1972-03       Impact factor: 4.965

5.  Agranulocytosis caused by procainamide.

Authors:  B Hickson; R J Davidson; W Walker
Journal:  Scott Med J       Date:  1972-05       Impact factor: 0.729

6.  Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

Authors:  J Koch-Weser; S W Klein; L L Foo-Canto; J A Kastor; R W DeSanctis
Journal:  N Engl J Med       Date:  1969-12-04       Impact factor: 91.245

Review 7.  The use of procaine amide and lidocaine in the treatment of cardiac arrhythmias.

Authors:  J T Bigger; R H Heissenbuttel
Journal:  Prog Cardiovasc Dis       Date:  1969-05       Impact factor: 8.194

8.  Pharmacokinetic of procainamide in man.

Authors:  J Koch-Weser
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

9.  Polymorphic acetylation procainamide in man.

Authors:  M M Reidenberg; D E Drayer; M Levy; H Warner
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

10.  Antinuclear antibodies during procainamide treatment and drug acetylation.

Authors:  D M Davies; M A Beedie; M D Rawlins
Journal:  Br Med J       Date:  1975-09-20
View more
  4 in total

Review 1.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

2.  The pharmacokinetics of slow-release procainamide.

Authors:  W J Tilstone; D H Lawson; W Campbell; I Hutton; T D Lawrie
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

3.  Computational models for the prediction of adverse cardiovascular drug reactions.

Authors:  Salma Jamal; Waseem Ali; Priya Nagpal; Sonam Grover; Abhinav Grover
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

4.  Metoclopramide: A Safe Alternative to Domperidone? A Case Report on Severe Cardiac Adverse Effects in an Older Patient.

Authors:  Laura C Sijtsma; Carolina J P W Keijsers; Angèle P M Kerckhoffs; Willem R P Agema; Janet E M Bootsma
Journal:  Drug Saf Case Rep       Date:  2018-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.